Haab F - Search Results

1

Patient-perceived outcomes in the treatment of stress urinary incontinence: focus on urethral injection therapy.

Chapple CR, Brubaker L, Haab F, van Kerrebroeck P, Robinson D. Chapple CR, et al. Among authors: haab f. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Feb;18(2):199-205. doi: 10.1007/s00192-006-0148-0. Epub 2006 Jul 18. Int Urogynecol J Pelvic Floor Dysfunct. 2007. PMID: 16847584 Review.

2

The pharmacological treatment of urinary incontinence.

Andersson KE, Appell R, Cardozo LD, Chapple C, Drutz HP, Finkbeiner AE, Haab F, Vela Navarrete R. Andersson KE, et al. Among authors: haab f. BJU Int. 1999 Dec;84(9):923-47. doi: 10.1046/j.1464-410x.1999.00397.x. BJU Int. 1999. PMID: 10571617 Review. No abstract available.

3

Improved quality of life in patients with overactive bladder symptoms treated with solifenacin.

Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM. Kelleher CJ, et al. Among authors: haab f. BJU Int. 2005 Jan;95(1):81-5. doi: 10.1111/j.1464-410X.2004.05255.x. BJU Int. 2005. PMID: 15638900

4

A critical review of diagnostic criteria for evaluating patients with symptomatic stress urinary incontinence.

Chapple CR, Wein AJ, Artibani W, Brubaker L, Haab F, Heesakkers JP, Lightner D. Chapple CR, et al. Among authors: haab f. BJU Int. 2005 Feb;95(3):327-34. doi: 10.1111/j.1464-410X.2005.05293.x. BJU Int. 2005. PMID: 15679788 Review.

5

The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects.

Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F, Khullar V, Versi E. Chapple CR, et al. Among authors: haab f. BJU Int. 2005 Feb;95(3):335-40. doi: 10.1111/j.1464-410X.2005.05294.x. BJU Int. 2005. PMID: 15679789 Review.

6

Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.

Haab F, Cardozo L, Chapple C, Ridder AM; Solifenacin Study Group. Haab F, et al. Eur Urol. 2005 Mar;47(3):376-84. doi: 10.1016/j.eururo.2004.11.004. Epub 2005 Jan 5. Eur Urol. 2005. PMID: 15716204 Clinical Trial.

7

An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.

Chapple CR, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A, Sultan AH. Chapple CR, et al. Among authors: haab f. Eur Urol. 2005 Sep;48(3):488-94. doi: 10.1016/j.eururo.2005.05.007. Eur Urol. 2005. PMID: 15967568 Clinical Trial.

8

Stress incontinence injection therapy: what is best for our patients?

Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F, Hill S. Chapple CR, et al. Among authors: haab f. Eur Urol. 2005 Oct;48(4):552-65. doi: 10.1016/j.eururo.2005.06.012. Eur Urol. 2005. PMID: 16118034 Review.

9

Overactive bladder: The importance of new guidance.

Kirby M, Artibani W, Cardozo L, Chapple C, Diaz DC, De Ridder D, Espuna-Pons M, Haab F, Kelleher C, Milsom I, Van Kerrebroeck P, Vierhout M, Wagg A. Kirby M, et al. Among authors: haab f. Int J Clin Pract. 2006 Oct;60(10):1263-71. doi: 10.1111/j.1742-1241.2006.01127.x. Int J Clin Pract. 2006. PMID: 16981970 Review.

10

Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ).

Basra R, Artibani W, Cardozo L, Castro-Diaz D, Chapple C, Cortes E, De Ridder D, Pons ME, Haab F, Hohenfellner M, Kirby M, Milsom I, Van Kerrebroeck P, Vierhout M, Wagg A, Kelleher C. Basra R, et al. Among authors: haab f. Eur Urol. 2007 Jul;52(1):230-7. doi: 10.1016/j.eururo.2006.11.015. Epub 2006 Nov 15. Eur Urol. 2007. PMID: 17129667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters